Skip to main content
SpringerLink
Log in

Management of Chronic Metabolic Acidosis

  • Chapter
  • First Online:
Metabolic Acidosis

Abstract

Many individuals have a net increase in hydrogen ion (H+) content of body fluids caused by gain of acid (H+) or loss of base (usually HCO3) that constitutes a dynamic process called metabolic acidosis. Untreated metabolic acidosis is associated with increased mortality and morbidity and should therefore be treated. Acute metabolic acidosis is best treated by correcting the underlying disorder causing the metabolic acidosis and in selected circumstances, with Na+-based alkali, usually NaHCO3. Chronic metabolic acidosis is typically and most appropriately treated with dietary H+ reduction using Na+-based alkali and/or with addition of base-producing foods such as fruits and vegetables.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. US Burden of Disease Collaborators. The state of US health, 1990–2010. Burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–608.

    Google Scholar 

  2. KDIGO Guidelines. Chapter 3: management of progression and complications of CKD. Kidney Int. 2013;Suppl 3:73–90.

    Google Scholar 

  3. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant. 2009;24:1232–7.

    Google Scholar 

  4. Raphael K, Wei G, Baird B, et al. Higher plasma bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int. 2011;79:356–62.

    Google Scholar 

  5. Shah SN, Abramowitz M, Hostetter TH, et al. Plasma bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis. 2009;54:270–7.

    Google Scholar 

  6. Dobre MD, Yang W, Chen J, et al. Association of plasma bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2013;62:670–8.

    Google Scholar 

  7. Wesson DE, Simoni J. Increased tissue acid mediates progressive GFR decline in animals with reduced nephron mass. Kidney Int. 2009;75:929–35.

    Google Scholar 

  8. Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int. 2010;78:1128–35.

    Google Scholar 

  9. Wesson DE, Simoni J, Broglio K, Sheather S. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol. 2011;300:F830–7.

    Google Scholar 

  10. Sebastian A, Harris ST, Ottaway JH, Todd KM, Morris Jr RC. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med. 1994;330:1776–81.

    Google Scholar 

  11. Remer T. Influence of nutrition on acid-base balance-metabolic aspects. Eur J Nutr. 2001;40:214–20.

    Google Scholar 

  12. Goraya N, Simoni J, Jo C-H, Wesson DE. Dietary acid reduction with fruits and vegetables or sodium bicarbonate reduces kidney injury in individuals with moderately reduced GFR due to hypertensive nephropathy. Kidney Int. 2011;81:86–93.

    Google Scholar 

  13. Frassetto LA, Todd K, Morris Jr RC, Sebastian A. Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr. 1998;68:576–83.

    Google Scholar 

  14. Goraya N, Simoni J, Jo C-H, Wesson DE. Comparison of treating the metabolic acidosis of CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8:371–81.

    Google Scholar 

  15. Goraya N, Simoni J, Jo C-H, Wesson DE. Treatment of metabolic acidosis in individuals with stage 3 CKD with fruits and vegetables or oral NaHCO3 reduces urine angiotensinogen and preserves GFR. Kidney Int. 2014;86:1031–8.

    Google Scholar 

  16. Adeva MM, Souto G. Diet-induced metabolic acidosis. Clin Nutr. 2011;30:416–21.

    Google Scholar 

  17. Kurtz I, Maher T, Hulter HN, et al. Effect of diet on plasma acid-base composition in normal humans. Kidney Int. 1983;24:670–80.

    Google Scholar 

  18. Lemann Jr J, Bushinsky DA, Hamm LL. Bone buffering of acid and base in humans. Am J Physiol Renal Physiol. 2003;285:F811–32.

    Google Scholar 

  19. Mahajan A, Simoni J, Sheather S, Broglio K, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 2010;78:303–9.

    Google Scholar 

  20. McSherry E. Renal tubular acidosis in childhood. Kidney Int. 1981;20:799–809.

    Google Scholar 

  21. Brenner RJ, Spring DB, Sebastian A, McSherry EM, Palubinskas AJ, Morris Jr RC. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982;307:217–21.

    Google Scholar 

  22. Caruana RJ, Buckalew Jr VM. The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine (Baltimore). 1988;67:84–99.

    Google Scholar 

  23. Kurtzman NA. Disorders of distal acidification. Kidney Int. 1990;38:720–7.

    Google Scholar 

  24. Coe FL, Parks JH. Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980;93:60–61.

    Google Scholar 

  25. Goodman AD, Lemann Jr J, Lennon EJ, Relman AS. Production, excretion, and net balance of fixed acid in patients with renal failure. J Clin Invest. 1980;17:595–606.

    Google Scholar 

  26. Wesson DE, Jo C-H, Simoni J. Animals with reduced GFR but no metabolic acidosis nevertheless have increased distal nephron acidification that is induced by acid retention and mediated through angiotensin II receptors. Kidney Int. 2012;82:1184–94.

    Google Scholar 

  27. Schwartz WB, Orning KJ, Porter R. The internal distribution of hydrogen ions with varying degrees of metabolic acidosis. J Clin Invest. 1957;36:373–82.

    Google Scholar 

  28. Kancir CB, Petersen PH, Madsen T. Effects of erythrocytes, bicarbonate, temperature, and albumin on in vitro ionized calcium variations with pH. Scand J Clin Lab Invest. 1989;49:475–82.

    Google Scholar 

  29. Levraut J, Garcia P, Giunti C, Ichai C, Bouregba M, Ciebiera JP, Payan P, Grimaud D. The increase in CO2 production induced by NaHCO3 depends on blood albumin and hemoglobin concentrations. Intensive Care Med. 2000;26:558–64.

    Google Scholar 

  30. Nolan C, Califano JR, Butzin CA. Influence of calcium acetate or calcium citrate on intestinal aluminum absorption. Kidney Int. 1990;38:937–41.

    Google Scholar 

  31. de Brito-Ashurst I, Varagunam M, Raferty MJ, Yaqoob M. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20:2075–84.

    Google Scholar 

  32. Susantitaphong P, Sewaralthahab K, Balk EM, et al. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol. 2012;35:540–7.

    Google Scholar 

  33. Abramowitz MK, Melamed ML, Bauer C, et al. Effects of oral sodium bicarbonate on patients with CKD. Clin J Am Soc Nephrol. 2013;8:714–20.

    Google Scholar 

  34. Loniewski I, Wesson DE. Bicarbonate therapy for kidney disease. Kidney Int. 2014;85:529–35.

    Google Scholar 

  35. Husted FC, Nolph KD. NaHCO3 and NaCl tolerance in chronic renal failure. Clin Nephrol. 1977;7:21–5.

    Google Scholar 

  36. Block GA, Wheeler DC, Persky MS, et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012;23:1407–15.

    Google Scholar 

  37. Mathur RP, Dash SC, Gupta N, et al. Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial. Ren Fail. 2006;28:1–5.

    Google Scholar 

  38. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95:791–7.

    Google Scholar 

  39. Barsotti G, Morelli E, Cupisti A, Meola M, Dani L, Giovannetti S. A low-nitrogen low phosphorous vegan diet for patients with chronic renal failure. Nephron. 1996;74:390–4.

    Google Scholar 

Download references

Conflict of Interest Statement

The author has no conflicts to report.

Author information

Authors and Affiliations

  1. Baylor Scott and White Health, Department of Internal Medicine, Texas A&M Health Sciences Center College of Medicine, 2401 South 31st Street, Temple, TX, 76508, USA

    Donald E. Wesson M.D., M.B.A.

Authors
  1. Donald E. Wesson M.D., M.B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald E. Wesson M.D., M.B.A. .

Editor information

Editors and Affiliations

  1. Baylor Scott & WhiteHealth Dept Int Med., Texas A&M Health Sci. Cent. Collg of Med, Temple, Texas, USA

    Donald E. Wesson

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

E. Wesson, D. (2016). Management of Chronic Metabolic Acidosis. In: E. Wesson, D. (eds) Metabolic Acidosis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3463-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3463-8_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3461-4

  • Online ISBN: 978-1-4939-3463-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation